DEPDC1B is recently found to be overexpressed in oral cancer and is capable of mediating anchorage-independent growth of oral cancer cells and promoting cell growth and invasion by interacting with Rac1 protein [17], making it a potential proteomic based biomarker as well as a therapeutic target for the purpose of curing the disease. Here, RAC1 is linked to lip and oral cavity carcinoma.